FDA Inspection 1231137 — The American National Red Cross Diagnostic Manufacturing Division
The FDA completed an inspection of The American National Red Cross Diagnostic Manufacturing Division on Feb 13, 2024 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gaithersburg, MD (United States)